E-LIB Suche - Ergebnisse für: De la Fouchardière, Christelle

1

Sunitinib for metastatic progressive phaeochromocytomas and..:

Baudin, Eric ; Goichot, Bernard ; Berruti, Alfredo...
The Lancet. 403 (2024) 10431 - p. 1061-1070 , 2024

Link: https://doi.org/10.1016/..

2

A multicenter study evaluating efficacy of immune checkpoin..:

Moreau, Mathilde ; Alouani, Emily ; Flecchia, Clémence...
European Journal of Cancer. 202 (2024) - p. 114033 , 2024

Link: https://doi.org/10.1016/..

3

Biliary tract cancers: French national clinical practice gu..:

Roth, Gael S. ; Verlingue, Loic ; Sarabi, Matthieu...
European Journal of Cancer. 202 (2024) - p. 114000 , 2024

Link: https://doi.org/10.1016/..

4

Triplet chemotherapy plus cetuximab as first-line treatment..:

Samalin, Emmanuelle ; Mazard, Thibault ; Assenat, Eric...
Digestive and Liver Disease. , 2024

Link: https://doi.org/10.1016/..

5

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ..:

Botsen, Damien ; Chabaud, Sylvie ; Perrier, Hervé...
Digestive and Liver Disease. , 2024

Link: https://doi.org/10.1016/..

6

Atezolizumab plus modified docetaxel, cisplatin, and fluoro..:

Kim, Stefano ; Ghiringhelli, Francois ; de la Fouchardière, Christelle...
The Lancet Oncology. 25 (2024) 4 - p. 518-528 , 2024

Link: https://doi.org/10.1016/..

7

Safety and efficacy of nintedanib as second-line therapy fo..:

Leboulleux, Sophie ; Kapiteijn, Ellen ; Litière, Saskia...
Frontiers in Endocrinology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

8

Improved guidance is needed to optimise diagnostics and tre..:

de la Fouchardière, Christelle ; Fugazzola, Laura ; Locati, Laura D....
Endocrine. 83 (2023) 3 - p. 585-593 , 2023

Link: https://doi.org/10.1007/..

9

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatmen..:

Wainberg, Zev A ; Melisi, Davide ; Macarulla, Teresa...
The Lancet. 402 (2023) 10409 - p. 1272-1281 , 2023

Link: https://doi.org/10.1016/..

10

Antitumour activity of neratinib in patients with HER2-muta..:

Harding, James J. ; Piha-Paul, Sarina A. ; Shah, Ronak H....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

DCF versus doublet chemotherapy as first-line treatment of ..:

Kim, Stefano ; Vendrely, Véronique ; Saint, Angélique...
Experimental Hematology & Oncology. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

12

Recommandations conjointes du réseau National ENDOCAN-COMET..:

Libé, Rossella ; Haissaguerre, Magalie ; Renaudin, Karine...
Bulletin du Cancer. 110 (2023) 6 - p. 707-730 , 2023

Link: https://doi.org/10.1016/..

13

Prognostic value of Lynch syndrome, BRAFV600E, and RAS muta..:

Zwart, Koen ; van der Baan, Frederieke H. ; Cohen, Romain...
Cancer Medicine. 12 (2023) 15 - p. 15841-15853 , 2023

Link: https://doi.org/10.1002/..

14

Primary resistance to immunotherapy in patients with a dMMR..:

Flecchia, Clémence ; Auclin, Edouard ; Alouani, Emily...
British Journal of Cancer. 130 (2023) 3 - p. 442-449 , 2023

Link: https://doi.org/10.1038/..

15

Targeting HER2 in metastatic gastroesophageal adenocarcinom..:

Coutzac, Clélia ; Funk-Debleds, Paméla ; Cattey-Javouhey, Anne...
Bulletin du Cancer. 110 (2023) 5 - p. 552-559 , 2023

Link: https://doi.org/10.1016/..